Literature DB >> 1474556

Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

P J Gaffney1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1474556      PMCID： PMC1293730          DOI： 10.1177/014107689208501112

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  19 in total

Review 1.  Basic and clinical aspects of fibrinolysis and thrombolysis.

Authors:  D Collen; H R Lijnen
Journal:  Blood       Date:  1991-12-15       Impact factor: 22.113

2.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

3.  Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin.

Authors:  S M Camiolo; S Thorsen; T Astrup
Journal:  Proc Soc Exp Biol Med       Date:  1971-10

4.  Roles for chloride ion and fibrinogen in the activation of [Glu1]plasminogen in human plasma.

Authors:  P J Gaffney; T Urano; V S de Serrano; M Mahmoud-Alexandroni; A R Metzger; F J Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Mutant and chimeric recombinant plasminogen activators. Production in eukaryotic cells and preliminary characterization.

Authors:  L Piérard; P Jacobs; D Gheysen; M Hoylaerts; B André; L Topisirovic; A Cravador; F de Foresta; A Herzog; D Collen
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

6.  Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.

Authors:  F Van de Werf; P A Ludbrook; S R Bergmann; A J Tiefenbrunn; K A Fox; H de Geest; M Verstraete; D Collen; B E Sobel
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

7.  Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.

Authors:  D Collen; J M Stassen; M Verstraete
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

8.  Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

Authors:  F Van de Werf; A E Arnold
Journal:  BMJ       Date:  1988-11-26

9.  Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator.

Authors:  M Verstraete; R Bernard; M Bory; R W Brower; D Collen; D P de Bono; R Erbel; W Huhmann; R J Lennane; J Lubsen
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

10.  Fibrin subunits in venous and arterial thromboembolism.

Authors:  P J Gaffney; M Brasher; K Lord; C J Strachan; A R Wilkinson; V V Kakkar; M F Scully
Journal:  Cardiovasc Res       Date:  1976-07       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.